1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 91-100 of 132 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2021The effect of lifestyle intervention on diabetes prevention by ethnicity: A systematic review of intervention characteristics using the TIDieR frameworkChen, M.; Ukke, G.G.; Moran, L.J.; Sood, S.; Bennett, C.J.; Khomami, M.B.; Absetz, P.; Teede, H.; Harrison, C.L.; Lim, S.
2021Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease.Jiang, S.H.; Mercan, S.; Papa, I.; Moldovan, M.; Walters, G.D.; Koina, M.; Fadia, M.; Stanley, M.; Lea-Henry, T.; Cook, A.; Ellyard, J.; McMorran, B.; Sundaram, M.; Thomson, R.; Canete, P.F.; Hoy, W.; Hutton, H.; Srivastava, M.; McKeon, K.; de la Rúa Figueroa, I.; et al.
2021HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disordersLe Clerc, S.; Lombardi, L.; Baune, B.T.; Amare, A.T.; Schubert, K.O.; Hou, L.; Clark, S.R.; Papiol, S.; Cearns, M.; Heilbronner, U.; Degenhardt, F.; Tekola-Ayele, F.; Hsu, Y.-H.; Shekhtman, T.; Adli, M.; Akula, N.; Akiyama, K.; Ardau, R.; Arias, B.; Aubry, J.-M.; et al.
2021Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients with Difficult to Cure CharacteristicsPapaluca, T.; Roberts, S.K.; Strasser, S.I.; Stuart, K.A.; Farrell, G.; Macquillan, G.; Dore, G.J.; Wade, A.J.; George, J.; Hazeldine, S.; O'Beirne, J.; Wigg, A.; Fisher, L.; McGarity, B.; Sawhney, R.; Sinclair, M.; Thomas, J.; Valiozis, I.; Weltman, M.; Wilson, M.; et al.
2021Association of global coagulation profiles with cardiovascular risk factors and atherosclerosis: A sex disaggregated analysis from the BioHEART-CT studyKott, K.A.; Morel-Kopp, M.C.; Vernon, S.T.; Takagi, Y.; Di Bartolo, B.A.; Peter, K.; Yang, J.Y.; Grieve, S.M.; Ward, C.; Figtree, G.A.
2021Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesityCao, E.; Watt, M.J.; Nowell, C.J.; Quach, T.; Simpson, J.S.; De Melo Ferreira, V.; Agarwal, S.; Chu, H.; Srivastava, A.; Anderson, D.; Gracia, G.; Lam, A.; Segal, G.; Hong, J.; Hu, L.; Phang, K.L.; Escott, A.B.J.; Windsor, J.A.; Phillips, A.R.J.; Creek, D.J.; et al.
2021Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T alleleBordin Andriguetti, N.; Van Schalkwyk, H.K.; Barratt, D.T.; Tucci, J.; Pumuye, P.; Somogyi, A.A.
2021Early medical abortion services provided in Australian primary careSubasinghe, A.K.; McGeechan, K.; Moulton, J.E.; Grzeskowiak, L.E.; Mazza, D.
2021Transcriptional signature in microglia associated with Aβ plaque phagocytosisGrubman, A.; Choo, X.Y.; Chew, G.; Ouyang, J.F.; Sun, G.; Croft, N.P.; Rossello, F.J.; Simmons, R.; Buckberry, S.; Landin, D.V.; Pflueger, J.; Vandekolk, T.H.; Abay, Z.; Zhou, Y.; Liu, X.; Chen, J.; Larcombe, M.; Haynes, J.M.; McLean, C.; Williams, S.; et al.
2021Association between bone measures and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockersHolloway-Kew, K.L.; Betson, A.G.; Anderson, K.B.; Gaston, J.; Kotowicz, M.A.; Liao, W.-H.; Henneberg, M.; Pasco, J.A.

Discover